Waqoo Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,731M | ¥1,726M | ¥1,943M | ¥1,961M |
| Gross Profit | ¥1,929M | ¥1,312M | ¥1,549M | ¥1,559M |
| Operating Income | -¥40M | ¥278M | ¥56M | ¥151M |
| Pretax Income | -¥17M | ¥37M | ¥62M | ¥161M |
| Net Income | -¥57M | ¥28M | -¥17M | ¥44M |
| EPS | -¥19.04 | ¥9.32 | -¥5.03 | ¥12.24 |
| Operating Margin | -1.46% | 16.10% | 2.89% | 7.70% |
| Balance Sheet | ||||
| Total Assets | ¥1,563M | ¥1,581M | ¥3,134M | ¥3,199M |
| Total Equity | ¥743M | ¥773M | ¥2,140M | ¥2,092M |
| Total Liabilities | ¥821M | ¥809M | ¥993M | ¥1,108M |
| Cash | ¥906M | ¥1,305M | ¥1,505M | ¥1,302M |
| Interest-bearing Debt | ¥646M | ¥636M | ¥783M | ¥731M |
| Equity Ratio | 47.50% | 48.87% | 68.30% | 65.38% |
| D/E Ratio | 0.87 | 0.82 | 0.37 | 0.35 |
| Cash Flow | ||||
| Operating CF | ¥169M | ¥456M | ¥49M | ¥136M |
| Investing CF | -¥176M | -¥49M | -¥76M | -¥189M |
| Financing CF | -¥129M | -¥8M | ¥112M | -¥150M |
| Free CF | ¥169M | ¥456M | -¥31M | -¥57M |
| Efficiency | ||||
| ROE | -7.70% | 3.67% | -0.81% | 2.11% |
| ROA | -3.66% | 1.79% | -0.56% | 1.38% |
Latest IR Information
-
Financial Summary / Earnings Report
Based on the financial summary, explains revisions to the FY2026 earnings outlook, the positioning of the D2C business, the introduction of shareholder benefits, and other measures to optimize the business structure and engage investors.
Read more -
Dialogue with Institutional Investors Regarding the Second Quarter Financial Results for the Fiscal Year Ending September 2026
Read more
Latest News (5 items)
Company Information
About
Waqoo Inc. engages in the planning, development, and sale of original brand cosmetics in Japan. It offers skin care products, such as cleansing, facial cleanser, hot cleansing, whitening serum, whitening face wash, and whitening cleansing products; proteins; makeup base; and hair care products, including hair oil and mask, and head spa hair growth agent products under the HADANATURE brand through its own e-commerce site. Additionally, it provides contract processing services for blood-derived products in the regenerative medicine field. It also sells cosmetics and raw materials and is expanding its business to develop new products and strengthen existing brands through marketing activities. The company serves consumers, patients, and medical institutions, primarily in Japan. The company was incorporated in 2005 and is based in Tokyo, Japan. Waqoo Inc. operates as a subsidiary of SBC Medical Group Co., Ltd.
